KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Updated efficacy and safety of HLX02 versus reference trastuzumab in metastatic HER2-positive breast cancer: A randomized phase III equivalence trial.

Breast · 2025-Apr · PMID 39954568

Panel A提取完成待 EXE 对齐验证

Progression-free survival

Kaplan–Meier estimates of investigator-assessed progression-free survival and overall survival. (a) progression-free survival and (b) overall survival in the intent-to-treat population ( n = 649); HLX02 ( n = 324), EU-trastuzumab ( n = 325). Tick marks indicate censoring of the data at the time of the last imaging assessment for PFS, and censoring of the data at the last known survival date for OS, respectively. Median survival and their 95 % CIs were derived using a Cox proportional hazard model with hormone receptor status, prior neo-/adjuvant therapy with trastuzumab, and ethnicity (Asian vs. non-Asian) as covariates. P-values were calculated using the stratified log-rank test. CI confidence interval, HR hazard ratio, NE not evaluable, NR not reached.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.72
质量通过是
预期曲线2
实际曲线2
X 范围-
Y 范围0 – 100

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

匹配 32 行
Curve序号X (norm)Y (norm)X (real)Y (real)X (pixel)Y (pixel)
110.00000.916094.37755627
120.06300.916094.37759927
130.06440.916094.377510027
140.06590.916094.377510127
150.06730.916094.377510227
160.06880.916094.377510327
170.07030.916094.377510427
180.07170.916094.377510527
190.07320.916094.377510627
1100.07470.916094.377510727
1110.07610.916094.377510827
1120.07760.916094.377510927
1130.07910.916094.377511027
1140.08050.916094.377511127
1150.08200.916094.377511227
1160.08350.916094.377511327
1170.08490.916094.377511427
210.00000.9695100.00005613
220.05560.954298.39369417
230.05710.954298.39369517
240.05860.935196.38559622
250.06000.927595.58239724
260.06150.927595.58239824
270.06300.923795.18079925
280.09660.885591.164712235
290.09810.877990.361412337
2100.09960.877990.361412437
2110.10100.877990.361412537
2120.10250.877990.361412637
2130.10400.870289.558212739
2140.10540.870289.558212839
2150.10690.870289.558212939
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0complete待验证22026-07-18T20:21:42+00:00